Do you have the same question? Follow this Question
Nov 06, 2025 - 11:56 AM
We’ve provided several answers to questions related to Baraclude (Entecavir) , see some other helpful Q&A related to this product.
Question: Should I get tested for HIV before starting this medication?
Answer: Yes, you should be tested for HIV infection before starting this medication, as using it in undiagnosed HIV can lead to drug resistance. Early detection of HIV ensures you receive the right treatment and avoid developing resistance.
Question: What are some of the identifiers for this medication in global drug databases?
Answer: Some identifiers include PubChem CID 135398508, ChEBI 473990, DrugBank DB00442, KEGG D04008, and ATC code J05AF10. These identifiers help healthcare professionals and researchers access consistent information about the medication across different systems.
Question: What is the bioavailability of this medicine?
Answer: The bioavailability is 70%, meaning that 70% of the drug is absorbed into the bloodstream when taken by mouth. A higher bioavailability ensures effective levels of medication reach the system for optimal treatment of hepatitis B.
